| The diagnosis of Cushing's syndrome: an endocrine society clinical practice guideline LK Nieman, BMK Biller, JW Findling, J Newell-Price, MO Savage, ... The Journal of Clinical Endocrinology & Metabolism 93 (5), 1526-1540, 2008 | 3046 | 2008 |
| Cushing's syndrome J Newell-Price, X Bertagna, AB Grossman, LK Nieman The Lancet 367 (9522), 1605-1617, 2006 | 1677 | 2006 |
| Diagnosis and complications of Cushing’s syndrome: a consensus statement G Arnaldi, A Angeli, AB Atkinson, X Bertagna, F Cavagnini, GP Chrousos, ... The Journal of Clinical Endocrinology & Metabolism 88 (12), 5593-5602, 2003 | 1671 | 2003 |
| Management of adrenal incidentalomas: European society of endocrinology clinical practice guideline in collaboration with the European network for the study of adrenal tumors M Fassnacht, W Arlt, I Bancos, H Dralle, J Newell-Price, A Sahdev, ... European journal of endocrinology 175 (2), G1-G34, 2016 | 1629 | 2016 |
| Treatment of Cushing's syndrome: an endocrine society clinical practice guideline LK Nieman, BMK Biller, JW Findling, MH Murad, J Newell-Price, ... The Journal of Clinical Endocrinology & Metabolism 100 (8), 2807-2831, 2015 | 1237 | 2015 |
| The diagnosis and differential diagnosis of Cushing’s syndrome and pseudo-Cushing’s states J Newell-Price, P Trainer, M Besser, A Grossman Endocrine reviews 19 (5), 647-672, 1998 | 1101 | 1998 |
| Treatment of adrenocorticotropin-dependent Cushing’s syndrome: a consensus statement BMK Biller, AB Grossman, PM Stewart, S Melmed, X Bertagna, J Bertherat, ... The Journal of Clinical Endocrinology & Metabolism 93 (7), 2454-2462, 2008 | 1055 | 2008 |
| A 12-month phase 3 study of pasireotide in Cushing's disease A Colao, S Petersenn, J Newell-Price, JW Findling, F Gu, M Maldonado, ... New England Journal of Medicine 366 (10), 914-924, 2012 | 700 | 2012 |
| Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs) JK Ramage, A Ahmed, J Ardill, N Bax, DJ Breen, ME Caplin, P Corrie, ... gut 61 (1), 6-32, 2012 | 688 | 2012 |
| The ectopic adrenocorticotropin syndrome: clinical features, diagnosis, management, and long-term follow-up AM Isidori, GA Kaltsas, C Pozza, V Frajese, J Newell-Price, RH Reznek, ... The Journal of Clinical Endocrinology & Metabolism 91 (2), 371-377, 2006 | 581 | 2006 |
| Complications of Cushing's syndrome: state of the art R Pivonello, AM Isidori, MC De Martino, J Newell-Price, BMK Biller, ... The lancet Diabetes & endocrinology 4 (7), 611-629, 2016 | 500 | 2016 |
| Consensus on diagnosis and management of Cushing's disease: a guideline update M Fleseriu, R Auchus, I Bancos, A Ben-Shlomo, J Bertherat, NR Biermasz, ... The lancet Diabetes & endocrinology 9 (12), 847-875, 2021 | 437 | 2021 |
| DNA methylation and silencing of gene expression J Newell-Price, AJL Clark, P King Trends in Endocrinology & Metabolism 11 (4), 142-148, 2000 | 411 | 2000 |
| Modified-release hydrocortisone to provide circadian cortisol profiles M Debono, C Ghobadi, A Rostami-Hodjegan, H Huatan, MJ Campbell, ... The Journal of Clinical Endocrinology & Metabolism 94 (5), 1548-1554, 2009 | 376 | 2009 |
| A single sleeping midnight cortisol has 100% sensitivity for the diagnosis of Cushing's syndrome J Newell‐Price, P Trainer, L Perry, J Wass, A Grossman, M Besser Clinical endocrinology 43 (5), 545-550, 1995 | 296 | 1995 |
| A critical analysis of the value of simultaneous inferior petrosal sinus sampling in Cushing’s disease and the occult ectopic adrenocorticotropin syndrome GA Kaltsas, MG Giannulis, JDC Newell-Price, JE Dacie, C Thakkar, ... The Journal of Clinical Endocrinology & Metabolism 84 (2), 487-492, 1999 | 287 | 1999 |
| Weight‐related dosing, timing and monitoring hydrocortisone replacement therapy in patients with adrenal insufficiency PM Mah, RC Jenkins, A Rostami‐Hodjegan, J Newell‐Price, A Doane, ... Clinical endocrinology 61 (3), 367-375, 2004 | 283 | 2004 |
| Linkage of the angiotensinogen gene locus to human essential hypertension in African Caribbeans. M Caulfield, P Lavender, J Newell-Price, M Farrall, S Kamdar, H Daniel, ... The Journal of clinical investigation 96 (2), 687-692, 1995 | 278 | 1995 |
| Cortisol as a marker for increased mortality in patients with incidental adrenocortical adenomas M Debono, M Bradburn, M Bull, B Harrison, RJ Ross, J Newell-Price The Journal of Clinical Endocrinology & Metabolism 99 (12), 4462-4470, 2014 | 277 | 2014 |
| Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors and carcinoid symptoms refractory to available somatostatin analogues EM Wolin, B Jarzab, B Eriksson, T Walter, C Toumpanakis, MA Morse, ... Drug design, development and therapy, 5075-5086, 2015 | 211 | 2015 |
